Company / EPS (Diluted)
PROCEPT BioRobotics Corp EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.72
FY2025
5-year range
-$3.63 / -$1.72
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#134 of 155
Health Care
What the data says
PROCEPT BioRobotics Corp's eps (diluted) of $-1.72 is lower than 86% of companies in the Health Care sector (FY2025). Improved from $-2.24 to $-1.72 over the past 2 years.
Based on SEC 10-K filings.
-1.72 in FY2025.
Improved from $-2.24 to $-1.72 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 155This company -$1.72 Sector average $2.33
▼
-173.9% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 1.7% year-over-year.
- Ranks #134 out of 155 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.72 | +1.7% |
| FY2024 | -$1.75 | +21.9% |
| FY2023 | -$2.24 | -14.3% |
| FY2022 | -$1.96 | +46.0% |
| FY2021 | -$3.63 | +74.9% |
| FY2020 | -$14.47 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026